Sometimes the best opportunities are found in the laggards. Take medical technology (or medtech) stocks, for example. As a group, medtech stocks haven't performed well over the last year. However, their long-term potential should be great.

Two underperforming medtech stocks especially stand out. Both InMode (NASDAQ: INMD) and Outset Medical (NASDAQ: OM) reported their fourth-quarter results this week.

Which is the better medtech stock to buy? Here's how InMode and Outset stack up against each other.

Continue reading

Source Fool.com